06-10-2015 | Volunteers needed to take part in Keppra (Levetiracetam) response study

06 October 2015
print version share on facebook
'06-10-2015 | Volunteers needed to take part in Keppra (Levetiracetam) response study' image

People with epilepsy respond differently to anti-epileptic medication. As yet, there is no way of predicting who will respond well to medication.

With funding from Epilepsy Ireland and the Irish Research Council, Dr Sinead Heavin (pictured) and colleagues at the Royal College of Surgeons are conducting a study to look at the genetic profile of patients who are taking the anti-epileptic drug, levetiracetam (brand name Keppra).

The goal of the study is to identify genetic factors that might be useful in helping to predict which patients will respond well to particular treatments. In this way treatment for epilepsy could be more personalised and precise.

The researchers would like to speak to people who are seizure free while taking keppra. Taking part is very straightforward and involves nothing more than providing a blood sample. Patients attending any hospital/neurology team or under the care of their General Practitioner (GP) can volunteer.

If this is you, the team would like to hear from you. To find out more, please contact Sinéad Heavin, at 01-4022102 or email sineadheavin@rcsi.ie.

Click here to read more on the study

web design by ionic